Kristine E Ensrud1, Li-Yung Lui2, Peggy Cawthon2, Lisa Fredman3, Yelena Slinin4, Teresa Hillier5, Jane Cauley6, Muna Canales7. 1. Department of Medicine and Division of Epidemiology & Community Health, University of Minnesota, Minneapolis. Department of Medicine, VA Health Care System, Minneapolis, Minnesota. ensru001@umn.edu. 2. California Pacific Medical Center Research Institute, San Francisco. 3. Department of Epidemiology, Boston University, Massachusetts. 4. Department of Medicine and Department of Medicine, VA Health Care System, Minneapolis, Minnesota. 5. Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon. 6. Department of Epidemiology, University of Pittsburgh, Pennsylvania. 7. Department of Medicine, Malcom-Randall VA Medical Center, Gainesville, Florida. Department of Medicine, University of Florida, Gainesville.
Abstract
BACKGROUND: Serum biomarkers predicting physical performance in late life are uncertain. We tested the hypotheses that lower serum cystatin C (cysC) in older women is associated with good mobility 10 years later. METHODS: We conducted a longitudinal analysis of a prospective cohort of 1,384 women attending Year 10 and Year 20 examinations of the Study of Osteoporotic Fractures. Serum cysC was measured using Year 10 frozen serum specimens. Year 20 mobility was ascertained by the Short Physical Performance Battery; scores of 10-12 indicated good mobility. RESULTS: At Year 20, mean age was 87.5 years and 364 women (26.3%) had good mobility. After adjustment for age, race, education, health status, diabetes, cardiovascular disease, and body mass index, lower cysC at Year 10 was associated with a higher likelihood of good mobility at Year 20. Compared with quartile (Q) 4 of cysC (referent group), odds ratios (95% confidence interval) were 1.52 (1.02-2.25) for Q3, 1.93 (1.32-2.84) for Q2 and 1.80 (1.21-2.67) for Q1 (p trend across Qs .003). The association was only modestly attenuated after further adjustment for mobility as assessed by a modified Short Physical Performance Battery at Year 10 (p trend .02) or consideration of potential biologic mediators including Year 10 levels of serum 25-hydroxyvitamin D, interleukin 6, and cytokine soluble receptors (p trend .04). CONCLUSIONS: Lower cysC in older women is independently associated with good mobility 10 years later and may be a biomarker for successful aging as manifested by preservation of lower extremity performance in late life. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
BACKGROUND: Serum biomarkers predicting physical performance in late life are uncertain. We tested the hypotheses that lower serum cystatin C (cysC) in older women is associated with good mobility 10 years later. METHODS: We conducted a longitudinal analysis of a prospective cohort of 1,384 women attending Year 10 and Year 20 examinations of the Study of Osteoporotic Fractures. Serum cysC was measured using Year 10 frozen serum specimens. Year 20 mobility was ascertained by the Short Physical Performance Battery; scores of 10-12 indicated good mobility. RESULTS: At Year 20, mean age was 87.5 years and 364 women (26.3%) had good mobility. After adjustment for age, race, education, health status, diabetes, cardiovascular disease, and body mass index, lower cysC at Year 10 was associated with a higher likelihood of good mobility at Year 20. Compared with quartile (Q) 4 of cysC (referent group), odds ratios (95% confidence interval) were 1.52 (1.02-2.25) for Q3, 1.93 (1.32-2.84) for Q2 and 1.80 (1.21-2.67) for Q1 (p trend across Qs .003). The association was only modestly attenuated after further adjustment for mobility as assessed by a modified Short Physical Performance Battery at Year 10 (p trend .02) or consideration of potential biologic mediators including Year 10 levels of serum 25-hydroxyvitamin D, interleukin 6, and cytokine soluble receptors (p trend .04). CONCLUSIONS: Lower cysC in older women is independently associated with good mobility 10 years later and may be a biomarker for successful aging as manifested by preservation of lower extremity performance in late life. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
Authors: S R Cummings; D M Black; M C Nevitt; W S Browner; J A Cauley; H K Genant; S R Mascioli; J C Scott; D G Seeley; P Steiger Journal: JAMA Date: 1990-02-02 Impact factor: 56.272
Authors: Michael G Shlipak; Kunihiro Matsushita; Johan Ärnlöv; Lesley A Inker; Ronit Katz; Kevan R Polkinghorne; Dietrich Rothenbacher; Mark J Sarnak; Brad C Astor; Josef Coresh; Andrew S Levey; Ron T Gansevoort Journal: N Engl J Med Date: 2013-09-05 Impact factor: 91.245
Authors: Linda F Fried; Jung Sun Lee; Michael Shlipak; Glenn M Chertow; Christie Green; Jingzhong Ding; Tamara Harris; Anne B Newman Journal: J Am Geriatr Soc Date: 2006-05 Impact factor: 5.562
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Christine K Liu; Asya Lyass; Joseph M Massaro; Ralph B D'Agostino; Caroline S Fox; Joanne M Murabito Journal: J Gerontol A Biol Sci Med Sci Date: 2013-08-02 Impact factor: 6.053
Authors: Lesley A Stevens; Christopher H Schmid; Tom Greene; Liang Li; Gerald J Beck; Marshall M Joffe; Marc Froissart; John W Kusek; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: Kidney Int Date: 2008-12-31 Impact factor: 10.612
Authors: Mark J Sarnak; Ronit Katz; Linda F Fried; David Siscovick; Brian Kestenbaum; Stephen Seliger; Dena Rifkin; Russell Tracy; Anne B Newman; Michael G Shlipak Journal: Arch Intern Med Date: 2008-01-28